Skip to content
CATALOGS
NEWSROOM
Latest News
Publications
Press Releases
Videos
Posters
Conferences
CAREERS & CULTURE
CONTACT
General Inquiries
Customer Support
Technical Support
Global Distributor Support
LabPMM
LabPMM, LLC (USA)
LabPMM, GmbH (Germany)
LabPMM, GK (Japan)
MY ACCOUNT
Login
Create Account
INSTRUMENT
PRODUCTS
Next-Generation Sequencing
CE-IVD
Illumina®
Thermo Fisher®
RUO
Illumina®
Thermo Fisher®
MRD
LymphoTrack® Solutions
LeukoStrat® FLT3-ITD MRD Assay
LeukoStrat® NPM1 MRD Assay
Companion Diagnostics (CDx)
LeukoStrat® CDx FLT3
Mutation Assay
CE-IVDR
IVD (US)
IVD (JP)
ABI Fluorescence Detection
CE-IVD
Clonality
FLT3
RUO
Clonality
FLT3
Translocations
Gel Detection
RUO
Clonality
FLT3
Translocations
Digital PCR
LeukoStrat® KMT2A + MRD Assay
Software
Dockerized
LeukoStrat® FLT3-ITD MRD Software
LeukoStrat® NPM1 MRD Software
LymphoTrack® Enterprise Software – MiSeq™
IdentiClone® RUO TCRG 2.0 Software
LeukoStrat® KMT2A + MRD Software
Reagents
ASRs
Enzymes
Hi-Di Formamide
Controls
Master Mix Controls
DNA Controls
RNA Controls
MRD Controls
Product & Service Catalogs
CLINICAL LAB SERVICES
Clinical Lab Services Overview
The Laboratory for Personalized Molecular Medicine
®
(LabPMM
®
) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.
EXPLORE SERVICES ⟶
Flow Cytometry
Hematolymphoid Screening Panel
AML MRD Assay
CLL MRD Assay
Companion Diagnostic (CDx) Tests
CDx – USA
CDx – Germany
CDx – Japan
NGS Cancer Panels
MyAML
MyMRD
MRD NGS Tests
Clonality
FLT3 ITD
NPM1
Clonality NGS Tests
SHM
IGH
IGK
TRG
TRB
Targeted Genes
NPM1
Custom Assays
Licensure and Certifications
Product & Service Catalogs
BIOBANK REPOSITORY
DISEASES
Lymphoid
Mature B-cell
Mature T-cell
Lymphoma
Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).
LEARN MORE ⟶
Browse our comprehensive menu of product & testing services.
EXPLORE MENU ⟶
Myeloid
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Myeloproliferative Neoplasms (MPNs)
Myeloma
Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.
LEARN MORE ⟶
PARTNERSHIPS
Partnerships Overview
A proven strategy to accelerate drug approvals
EXPLORE PARTNERSHIPS ⟶
LEARN MORE ⟶
Product Development
Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays
EXPLORE ⟶
LEARN MORE ⟶
Manufacturing
cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents
EXPLORE ⟶
LabPMM®
Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment
EXPLORE ⟶
Global Regulatory Expertise
Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)
EXPLORE ⟶
SCIENCE
Science Overview
We take pride in expanding the science that bridges personalized medicine with quality healthcare.
EXPLORE OUR SCIENCE ⟶
Personalized Medicine
Personalized Molecular Medicine
®
is use of genomics and patient specific information to identify optimal treatment for each patient.
EXPLORE PERSONALIZED MEDICINE ⟶
PUBLICATIONS
Featured Publication
Measurable Residual
FLT3
Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
VIEW PUBLICATION
⟶
Latest Publications
Measurable Residual
FLT3
Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
VIEW PUBLICATION
⟶
Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing
VIEW PUBLICATION ⟶
Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma
VIEW PUBLICATION ⟶
Company
COMPANY
Leadership Team
Board of Directors
Legal Notices
Newsroom
Global Distributors
Licensure and Certifications
Careers & Culture
Shop Corporate Gear
Invivoscribe Locations
Invivoscribe, Inc. (USA)
San Diego, CA, US
CONTACT US ⟶
Invivoscribe, SARL (France)
Marseille, France
CONTACT US ⟶
Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
Shanghai, China
CONTACT US ⟶
Clinical Lab Locations
LabPMM, LLC (USA)
San Diego, CA, US
CONTACT US ⟶
LabPMM, GmbH (Germany)
Munich, Germany
CONTACT US ⟶
LabPMM, GK (Japan)
Kawasaki, Japan
CONTACT US ⟶
Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
Shanghai, China
CONTACT US ⟶
Support
Invivoscribe, Inc. (USA)
CONTACT US ⟶
Invivoscribe, SARL (France)
CONTACT US ⟶
Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
CONTACT US ⟶
LabPMM, LLC (USA)
CONTACT US ⟶
LabPMM, GmbH (Germany)
CONTACT US ⟶
LabPMM, GK (Japan)
CONTACT US ⟶
Search for:
Search
Search Articles & Publications
Search for:
Search Products & Services
SEARCH ⟶
Search Product Documents & IFUs
SEARCH ⟶
INSTRUMENT
PRODUCTS
Explore Products
Search Products
Search Product Documents & IFUs
Next-Generation Sequencing
CE-IVD
Illumina®
Thermo Fisher®
RUO
Illumina®
Thermo Fisher®
MRD
LymphoTrack® Solutions
LeukoStrat® FLT3-ITD MRD Assay
LeukoStrat® NPM1 MRD Assay
Companion Diagnostics (CDx)
LeukoStrat® CDx FLT3
Mutation Assay
CE-IVDR
IVD (US)
IVD (JP)
ABI Fluorescence Detection
CE-IVD
Clonality
FLT3
RUO
Clonality
FLT3
Translocations
Gel Detection
RUO
Clonality
FLT3
Translocations
Digital PCR
LeukoStrat® KMT2A + MRD Assay
Software
Dockerized
LeukoStrat® FLT3-ITD MRD Software
LeukoStrat® NPM1 MRD Software
LymphoTrack® Enterprise Software – MiSeq™
IdentiClone® RUO TCRG 2.0 Software
LeukoStrat® KMT2A + MRD Software
Reagents
ASRs
Enzymes
Hi-Di Formamide
Controls
Master Mix Controls
DNA Controls
RNA Controls
MRD Controls
Product & Service Catalogs
CLINICAL LAB SERVICES
Clinical Lab Services Overview
Flow Cytometry
Hematolymphoid Screening Panel
AML MRD Assay
CLL MRD Assay
Companion Diagnostic (CDx) Tests
CDx – USA
CDx – Germany
CDx – Japan
NGS Cancer Panels
MyAML
MyMRD
MRD NGS Tests
Clonality
FLT3 ITD
NPM1
Clonality NGS Tests
SHM
IGH
IGK
TRG
TRB
Targeted Genes
NPM1
Custom Assays
Licensure and Certifications
Product & Service Catalogs
BIOBANK REPOSITORY
DISEASES
Lymphoid
Mature B-cell
Mature T-cell
Lymphoma
Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).
LEARN MORE ⟶
Browse our comprehensive menu of product & testing services.
EXPLORE MENU ⟶
Mature B-cell
Mature T-cell
Myeloid
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Myeloproliferative Neoplasms (MPNs)
Myeloma
Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.
LEARN MORE ⟶
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Myeloproliferative Neoplasms (MPNs)
PARTNERSHIPS
Partnerships Overview
Product Development
Manufacturing
LabPMM®
Global Regulatory Expertise
SCIENCE
Science Overview
Personalized Medicine
PUBLICATIONS
Featured Publication
Latest Publications
NEWSROOM
Latest News
Publications
Press Releases
Videos
Posters
Conferences
CAREERS & CULTURE
COMPANY
Support
Company
About Us
Our Mission, Vision & Values
Leadership Team
Board of Directors
Legal Notices
Newsroom
Global Distributors
Licensure and Certifications
Shop Corporate Gear
Invivoscribe Locations
Invivoscribe, Inc. (USA)
Invivoscribe, SARL (France)
Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
Clinical Lab Locations
LabPMM, LLC (USA)
LabPMM, GmbH (Germany)
LabPMM, GK (Japan)
Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
CONTACT
Home
>
Newsroom
>
Posters
Posters
2025-11-17T10:14:38-08:00
Posters
Posters
2025
AMP
The LymphoTrack
®
Flex Assay: A High-Throughput NGS Assay for the Assessment of Clonality in Lymphoproliferative Diseases
DOWNLOAD ⟶
Performance Comparison of Invivoscribe’s B-cell and T-cell LymphoTrack
®
Assays between MiSeq
TM
and MiSeq i100
DOWNLOAD ⟶
KMT2A
Fusion Detection for Measurable Residual Disease in Acute Myeloid Leukemia Using a Novel Multiplex Digital PCR Assay
DOWNLOAD ⟶
Impact of reclassification and subcategorization of variants of uncertain significance in Acute Myeloid Leukemia Variants in AML
DOWNLOAD ⟶
Best Practices for the Detection, Interpretation, and Reporting of
In Cis
Variants in AML
DOWNLOAD ⟶
AACR
LymphoTrack
®
Enterprise Software v3.0.1: A High-Throughput Software Solution for Immunogenomic Analysis
DOWNLOAD ⟶
MyInformatics
®
– Streamlining End-to-End NGS Analysis with Automated, Containerized Workflows for Faster Results
DOWNLOAD ⟶
CGC
A Comparison of Clinical Expert to Software Analysis of T-Cell Receptor Gamma Gene Rearrangement Capillary Electrophoresis Datasets
DOWNLOAD ⟶
2024
ASH
Measurable Residual Mutated
NPM1
Before Allogenic Transplant For Acute Myeloid Leukemia
DOWNLOAD ⟶
AMP
MRD in AML Biomarkers Consortium: Evaluation of Methods for Detection of
FLT3
Internal Tandem Duplication Measurable Residual Disease in Acute Myeloid Leukemia
DOWNLOAD ⟶
High-Throughput Multiplex MRD Assay for Prognostic Markers in AML Utilizing DNBSEQ-G99 Sequencer
DOWNLOAD ⟶
The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)
DOWNLOAD ⟶
Assessment of
FLT3
Somatic Variant Oncogenicity using
FLT3
-Gene-Specific Guidelines in Acute Myeloid Leukemia
DOWNLOAD ⟶
The Challenges of Developing Classification Guidelines for Fusions in AML; How and When to Use a KMT2A Fusion-Specific Workflow
DOWNLOAD ⟶
AMP Europe
Performance Comparison of Nine Different Assays Between Next Generation Sequencing (NGS) Platforms
DOWNLOAD ⟶
IdentiClone
®
RUO
TCRG 2.0
Software for Capillary-Based Detection of T-Cell Receptor Gamma Gene Rearrangements
DOWNLOAD ⟶
2023
AMP
Artifact and Background Calculator Identifies Patterns of False Positive Variant Calls in Clinical NGS Panels
DOWNLOAD ⟶
Evaluation of a High-Throughput CDR3 Identification Algorithm for 1136 Clinical Samples Targeting the
IGHV
Leader,
IGH
FR1, and
TRG
Loci
DOWNLOAD ⟶
AMP Europe
Measurable Residual Disease Detection in Mantle Cell Lymphoma (MCL) Subjects Using NGS B-Cell MRD Assay
DOWNLOAD ⟶
EHA
A Prospective Study of TCR Measurable Residual Disease in Peripheral T-Cell Lymphoma
DOWNLOAD ⟶
ASCO
A Multi-Institutional Prospective Cohort Study of Minimal Residual Disease in Peripheral T-cell Lymphoma: Impact of Autologous Stem Cell Transplant
DOWNLOAD ⟶
2022
EAHP
Detecting Clonality in Mantle Cell Lymphoma (MCL) Subjects Using LymphoTrack® IGH FR1 Assays
DOWNLOAD ⟶
AMP
Validate an NGS Based Measurable Residual Disease (MRD) Assay for B-Cell Lymphoproliferative Diseases
DOWNLOAD ⟶
Tracking Measurable Residual Disease in Acute Myeloid Leukemia with Error Corrected Sequencing
DOWNLOAD ⟶
SNPrint: Customizable Genotyper for Clinical Sample Tracking and Disease Progression Monitoring for NGS-Based Targeted Gene Panels
DOWNLOAD ⟶
EHA
A Sensitive NGS Assay to Detect Measurable Residual Disease (MRD) in B-cell Lymphoproliferative Diseases
DOWNLOAD ⟶
2020
ASH
End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-cell Lymphomas
DOWNLOAD ⟶
EHA
TRG
Clonality Interrogation by CE and NGS: Bridging the Gap Between Classical and Leading Edge Technologies
DOWNLOAD ⟶
2019
AMP
A Next-Generation Sequencing Based Analysis of Clonality across 39 Subjects Treated for Lymphoproliferative Disorders Reveals Matching Clones in the Diverse
IGH
Locus
DOWNLOAD ⟶
Comparing DNA Extraction Methods for the LymphoTrack
®
IVD
TRG
Assay
DOWNLOAD ⟶
Evaluation of An Alternative Fragmentation Method in High Throughput NGS Sample Testing of Minimal Residual Disease in Hematological Malignancies
DOWNLOAD ⟶
Validation of an NGS based assay for monitoring
FLT3
ITD and TKD variants in AML subjects
DOWNLOAD ⟶
Comparing Minimal Residual Disease Detection in Multiple Myeloma using NGS-Based LymphoTrack
®
Assays and Flow Cytometry
DOWNLOAD ⟶
LymphoTrack
®
Low Positive Control and LymphoQuant
®
Internal Control for MiSeq
™
and Ion S5/PGM
™
LymphoTrack Assays
DOWNLOAD ⟶
Error Rate Normalization to Establish Position-Specific LoB & LoD in Next Generation Sequencing Assays
DOWNLOAD ⟶
2018
AMP
Minimal Residual Disease in AML can be Monitored Utilizing Cell-Free DNA
DOWNLOAD ⟶
Detection of Clonal Rearrangements in Multiple Myeloma Samples using LymphoTrack
®
Assays
DOWNLOAD ⟶
Performance Evaluation of LymphoTrack
®
Clonality Assays on Ion PGM<sup™ and Ion S5<sup™ Platforms
DOWNLOAD ⟶
EHA
Comparison of LymphoTrack
®
Assays – MiSeq
™
and Flow Cytometry for Clonality and Minimum Residual Disease Assessment in Multiple Myeloma
DOWNLOAD ⟶
Cell-Free DNA Monitoring of Minimal Residual Disease in AML using a Targeted NGS Gene Panel
DOWNLOAD ⟶
2017
AMP
Small Customizable Next-Generation Sequencing Based Target-Capture Panels in a Clinical Environment Can Detect Variant Mutations at Frequencies as Low as 0.5%
DOWNLOAD ⟶
Small Detecting B-Cell Clonality in Clinical Samples using a Comprehensive NGS LymphoTrack Dx
®
IGH
FR1/2/3 Assay
DOWNLOAD ⟶
Assessment of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Monitoring
FLT3
and
NPM1
Mutations
DOWNLOAD ⟶
Genetic Heterogeneity and Stratification of AML Samples with
NPM1
Mutation Detected by the MyAML
®
NGS Test
DOWNLOAD ⟶
Clonality Detection Using Next-Generation Sequencing and Capillary Electrophoresis Methods in Suspect Lymphoproliferative Samples
DOWNLOAD ⟶
Validation of the LeukoStrat
®
CDx
FLT3
Mutation Assay: Used to Detect both Internal Tandem Duplication (ITD) and Tyrosine Kinase Domain (TKD) Mutations and Response to Midostaurin in 1058 Patients with AML
DOWNLOAD ⟶
Multiple Highly Concordant Assays Facilitate Analyses of Clinical Samples at Different Scales and Sensitivities
DOWNLOAD ⟶
Detection of Clonal
TRG
and
TRB
Gene Rearrangements Using Next-Generation Sequencing
DOWNLOAD ⟶
Analysis and Characterization of Hematologic Cancers using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes
DOWNLOAD ⟶
EHA
Small Customizable NGS Based Target Capture Panels Detect Variants in Clinical Specimens at Frequencies as Low as 0.5%
DOWNLOAD ⟶
Use of a Small Targeted Next-Generation Sequencing Panel for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia
DOWNLOAD ⟶
Using Next-Generation Sequencing to Detect Clonal
TRG
and
TRB
Gene Rearrangements
DOWNLOAD ⟶
Detection of Clonality in Clinical Specimens from Suspected B-cell Malignancies using Comprehensive
IGH
(FR1/2/3) LymphoTrack
®
MiSeq
™
and PGM
™
Assays
DOWNLOAD ⟶
Analysis and Characterization of Hematologic Cancers using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes
IGH
(FR1/2/3) LymphoTrack
®
MiSeq
™
and PGM
™
Assays
DOWNLOAD ⟶
2016
AMP
Minimal Residual Disease Detection of Lymphoid and Plasma Cell Neoplasms Using a Next-Generation Sequencing (NGS)-Based Assay
DOWNLOAD ⟶
Detection of Clonal Immunoglobulin and T-cell Receptor Gene Rearrangements in Acute Myeloid Leukemia
DOWNLOAD ⟶
LOD and Sensitivity of MyHEME: A Comprehensive Targeted Sequencing Strategy
DOWNLOAD ⟶
Next-Generation Sequencing of
FLT3
/
ITD
for Minimal Residual Disease Monitoring in Leukemia Patients
DOWNLOAD ⟶
Next-Generation Sequencing of
NPM1
for Minimal Residual Disease Monitoring in Leukemia Patients
DOWNLOAD ⟶
Development of a Comprehensive
IGH
NGS Assay for Detecting Suspected B-Cell Clonality
DOWNLOAD ⟶
A Single Institution Experience Using Next Generation Sequencing (NGS) for Analysis of Immunoglobulin Heavy Chain Variable Region (IGVH) Somatic Hypermutation in Chronic Lymphocytic Leukemia
DOWNLOAD ⟶
Next Generation Sequencing Demonstrates Clinical Utility and Increased Sensitivity in Detection of IgVH Somatic Hypermutation in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
DOWNLOAD ⟶
Assessment of Immunoglobulin Heavy Variable Gene Usage and Somatic Hypermutation Status in Splenic Marginal Zone Lymphomas Using Next Generation Sequencing
DOWNLOAD ⟶
2015
AMP
Development of LymphoTrack
®
Bioinformatics Methods: Clonality Testing, Somatic Hypermutation and Minimal Residual Disease
DOWNLOAD ⟶
Validation and clinical implementation of next generation sequencing for routine
IGH
and
TCRG
clonality assessment
DOWNLOAD ⟶
Next-Generation Sequencing for Detection of Clonal
TRG
Gene Rearrangements Shows Improved Specificity and Positive Predictive Value Compared to Fragment Analysis Using BIOMED-2 Primers and Capillary Electrophoresis
DOWNLOAD ⟶
EHA
Clinical Assessment of Chronic Lymphocytic Leukemia (CLL) Samples for Somatic Hypermutation Status by Next-Generation Sequencing and Sanger Sequencing
DOWNLOAD ⟶
Development of an NGS Assay for
IGK
that can be combined with
IGH
for Identifying Clonal Populations in Lymphoid Malignancies
DOWNLOAD ⟶
2025
CGC
A Comparison of Clinical Expert to Software Analysis of T-Cell Receptor Gamma Gene Rearrangement Capillary Electrophoresis Datasets
DOWNLOAD ⟶
AACR
MyInformatics
®
– Streamlining End-to-End NGS Analysis with Automated, Containerized Workflows for Faster Results
DOWNLOAD ⟶
LymphoTrack
®
Enterprise Software v3.0.1: A High-Throughput Software Solution for Immunogenomic Analysis
DOWNLOAD ⟶
2024
AMP
High-Throughput Multiplex MRD Assay for Prognostic Markers in AML Utilizing DNBSEQ-G99 Sequencer
DOWNLOAD ⟶
The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)
DOWNLOAD ⟶
Assessment of
FLT3
Somatic Variant Oncogenicity using
FLT3
-Gene-Specific Guidelines in Acute Myeloid Leukemia
DOWNLOAD ⟶
The Challenges of Developing Classification Guidelines for Fusions in AML; How and When to Use a KMT2A Fusion-Specific Workflow
DOWNLOAD ⟶
AMP Europe
The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)
DOWNLOAD ⟶
2023
AMP
The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)
DOWNLOAD ⟶
Artifact and Background Calculator Identifies Patterns of False Positive Variant Calls in Clinical NGS Panels
DOWNLOAD ⟶
Evaluation of a High-Throughput CDR3 Identification Algorithm for 1136 Clinical Samples Targeting the
IGHV
Leader,
IGH
FR1, and
TRG
Loci
DOWNLOAD ⟶
AMP Europe
Measurable Residual Disease Detection in Mantle Cell Lymphoma (MCL) Subjects Using NGS B-Cell MRD Assay
DOWNLOAD ⟶
EHA
A Prospective Study of TCR Measurable Residual Disease in Peripheral T-Cell Lymphoma
DOWNLOAD ⟶
ASCO
A Multi-Institutional Prospective Cohort Study of Minimal Residual Disease in Peripheral T-cell Lymphoma: Impact of Autologous Stem Cell Transplant
DOWNLOAD ⟶
2022
EAHP
Detecting Clonality in Mantle Cell Lymphoma (MCL) Subjects Using LymphoTrack
®
IGH FR1 Assays
DOWNLOAD ⟶
AMP
Validate an NGS Based Measurable Residual Disease (MRD) Assay for B-Cell Lymphoproliferative Diseases
DOWNLOAD ⟶
Tracking Measurable Residual Disease in Acute Myeloid Leukemia with Error Corrected Sequencing
DOWNLOAD ⟶
SNPrint: Customizable Genotyper for Clinical Sample Tracking and Disease Progression Monitoring for NGS-Based Targeted Gene Panels
DOWNLOAD ⟶
EHA
A Sensitive NGS Assay to Detect Measurable Residual Disease (MRD) in B-cell Lymphoproliferative Diseases
DOWNLOAD ⟶
2020
ASH
End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-cell Lymphomas
DOWNLOAD ⟶
EHA
TRG
Clonality Interrogation by CE and NGS: Bridging the Gap Between Classical and Leading Edge Technologies
DOWNLOAD ⟶
2019
AMP
A Next-Generation Sequencing Based Analysis of Clonality across 39 Subjects Treated for Lymphoproliferative
Disorders Reveals Matching Clones in the Diverse
IGH
Locus
DOWNLOAD ⟶
Comparing DNA Extraction Methods for the LymphoTrack
®
IVD
TRG
Assay
DOWNLOAD ⟶
Evaluation of An Alternative Fragmentation Method in High Throughput NGS Sample Testing of Minimal Residual Disease in Hematological Malignancies
DOWNLOAD ⟶
Validation of an NGS based assay for monitoring
FLT3
ITD and TKD variants in AML subjects
DOWNLOAD ⟶
Comparing Minimal Residual Disease Detection in Multiple Myeloma using NGS-Based LymphoTrack
®
Assays and Flow Cytometry
DOWNLOAD ⟶
LymphoTrack® Low Positive Control and LymphoQuant
®
Internal Control for MiSeq
™
and Ion S5/PGM
™
LymphoTrack Assays
DOWNLOAD ⟶
Error Rate Normalization to Establish Position-Specific LoB & LoD in Next Generation Sequencing Assays
DOWNLOAD ⟶
2018
AMP
Minimal Residual Disease in AML can be Monitored Utilizing Cell-Free DNA
DOWNLOAD ⟶
Detection of Clonal Rearrangements in Multiple Myeloma Samples using LymphoTrack
®
Assays
DOWNLOAD ⟶
Performance Evaluation of LymphoTrack
®
Clonality Assays on Ion PGM™ and Ion S5™ Platforms
DOWNLOAD ⟶
EHA
Comparison of LymphoTrack
®
Assays – MiSeq
™
and Flow Cytometry for Clonality and Minimum Residual Disease Assessment in Multiple Myeloma
DOWNLOAD ⟶
Cell-Free DNA Monitoring of Minimal Residual Disease in AML using a Targeted NGS Gene Panel
DOWNLOAD ⟶
2017
AMP
Small Customizable Next-Genera5on Sequencing Based Target-Capture Panels in a Clinical Environment Can Detect Variant Muta5ons at Frequencies as Low as 0.5%
DOWNLOAD ⟶
Small Detec3ng B-Cell Clonality in Clinical Samples using a Comprehensive NGS LymphoTrack Dx
®
IGH FR1/2/3 Assay
DOWNLOAD ⟶
Assessment of Minimal Residual Disease in Pa3ents with Acute Myeloid Leukemia by Monitoring
FLT3
and
NPM1
Mutations
DOWNLOAD ⟶
Genetic Heterogeneity and Stratification of AML Samples with
NPM1
Mutation Detected by the MyAML
®
NGS Test
DOWNLOAD ⟶
Clonality Detection Using Next-Generation Sequencing and Capillary Electrophoresis Methods in Suspect Lymphoproliferative Samples
DOWNLOAD ⟶
Validation of the LeukoStrat
®
CDx FLT3 Mutation Assay: Used to Detect both Internal Tandem Duplication (ITD) and Tyrosine Kinase Domain (TKD) Mutations and Response to Midostaurin in 1058 Patients with AML
DOWNLOAD ⟶
Multiple Highly Concordant Assays Facilitate Analyses of Clinical Samples at Different Scales and Sensitivities
DOWNLOAD ⟶
Detection of Clonal TRG and TRB Gene Rearrangements Using Next-Generation Sequencing
DOWNLOAD ⟶
Analysis and Characterization of Hematologic Cancers using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes
DOWNLOAD ⟶
EHA
Small Customizable NGS Based Target Capture Panels Detect Variants in Clinical Specimens at Frequencies as Low as 0.5%
DOWNLOAD ⟶
Use of a Small Targeted Next-Generation Sequencing Panel for Monitoring Minimal Residual Disease in Acute Myeloid Leukemia
DOWNLOAD ⟶
Using Next-Generation Sequencing to Detect Clonal
TRG
and
TRB
Gene Rearrangements
DOWNLOAD ⟶
Detection of Clonality in Clinical Specimens from Suspected B-cell Malignancies using Comprehensive
IGH
(FR1/2/3) LymphoTrack
®
MiSeq
™
and PGM
®
Assays
DOWNLOAD ⟶
Analysis and Characterization of Hematologic Cancers using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes
IGH
(FR1/2/3) LymphoTrack
®
MiSeq
™
and PGM
®
Assays
DOWNLOAD ⟶
2016
AMP
Minimal Residual Disease Detection of Lymphoid and Plasma Cell Neoplasms Using a Next-Generation Sequencing (NGS)-Based Assay
DOWNLOAD ⟶
Detec1on of Clonal Immunoglobulin and T-cell Receptor Gene Rearrangements in Acute Myeloid Leukemia
DOWNLOAD ⟶
LOD and Sensi;vity of MyHEME: A Comprehensive Targeted Sequencing Strategy
DOWNLOAD ⟶
Next-Generation Sequencing of FLT3/ITD for Minimal Residual Disease Monitoring in
Leukemia Patients
DOWNLOAD ⟶
Next-Generation Sequencing of
NPM1
for Minimal Residual Disease Monitoring in Leukemia Patients
DOWNLOAD ⟶
Development of a Comprehensive IGH NGS Assay for DetecQng Suspected B-Cell Clonality
DOWNLOAD ⟶
A Single Institution Experience Using Next Generation Sequencing (NGS) for Analysis of Immunoglobulin Heavy Chain Variable Region (IGVH) Somatic Hypermutation in Chronic Lymphocytic Leukemia
DOWNLOAD ⟶
Next Generation Sequencing Demonstrates Clinical Utility and Increased Sensitivity in Detection of IgVH Somatic Hypermutation in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
DOWNLOAD ⟶
Assessment of Immunoglobulin Heavy Variable Gene Usage and Somatic Hypermutation Status in Splenic Marginal Zone Lymphomas Using Next Generation Sequencing
DOWNLOAD ⟶
2015
AMP
Development of LymphoTrack® Bioinformatics Methods: Clonality Testing, Somatic Hypermutation and Minimal Residual Disease
DOWNLOAD ⟶
Validation and clinical implementation of next generation sequencing for routine IGH and TCRG clonality assessment
DOWNLOAD ⟶
Next-Generation Sequencing for Detection of Clonal TRG Gene Rearrangements Shows Improved Specificity and Positive Predictive Value Compared to Fragment Analysis Using BIOMED-2 Primers and Capillary Electrophoresis
DOWNLOAD ⟶
EHA
Clinical Assessment of Chronic Lymphocytic Leukemia (CLL) Samples for Somatic Hypermutation Status by Next-Generation Sequencing and Sanger Sequencing
DOWNLOAD ⟶
Development of an NGS Assay for IGK that can be combined with IGH for Identifying Clonal Populations in Lymphoid Malignancies
DOWNLOAD ⟶
Global Search
SEARCH BY KEYWORD
Global Search
SEARCH BY KEYWORD
Looking for Product Documents?
Try our New Document Search Feature ⟶
Looking for Product Documents?
Try our New Document Search Feature ⟶
X
INSTRUMENT
PRODUCTS
Explore Products
Search Products
Search Product Documents & IFUs
Next-Generation Sequencing
CE-IVD
Illumina®
Thermo Fisher®
RUO
Illumina®
Thermo Fisher®
MRD
LymphoTrack® Solutions
LeukoStrat® FLT3-ITD MRD Assay
LeukoStrat® NPM1 MRD Assay
Companion Diagnostics (CDx)
LeukoStrat® CDx FLT3
Mutation Assay
CE-IVDR
IVD (US)
IVD (JP)
ABI Fluorescence Detection
CE-IVD
Clonality
FLT3
RUO
Clonality
FLT3
Translocations
Gel Detection
RUO
Clonality
FLT3
Translocations
Digital PCR
LeukoStrat® KMT2A + MRD Assay
Software
Dockerized
LeukoStrat® FLT3-ITD MRD Software
LeukoStrat® NPM1 MRD Software
LymphoTrack® Enterprise Software – MiSeq™
IdentiClone® RUO TCRG 2.0 Software
LeukoStrat® KMT2A + MRD Software
Reagents
ASRs
Enzymes
Hi-Di Formamide
Controls
Master Mix Controls
DNA Controls
RNA Controls
MRD Controls
Product & Service Catalogs
CLINICAL LAB SERVICES
Clinical Lab Services Overview
Flow Cytometry
Hematolymphoid Screening Panel
AML MRD Assay
CLL MRD Assay
Companion Diagnostic (CDx) Tests
CDx – USA
CDx – Germany
CDx – Japan
NGS Cancer Panels
MyAML
MyMRD
MRD NGS Tests
Clonality
FLT3 ITD
NPM1
Clonality NGS Tests
SHM
IGH
IGK
TRG
TRB
Targeted Genes
NPM1
Custom Assays
Licensure and Certifications
Product & Service Catalogs
BIOBANK REPOSITORY
DISEASES
Lymphoid
Mature B-cell
Mature T-cell
Myeloid
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Myeloproliferative Neoplasms (MPNs)
PARTNERSHIPS
Partnerships Overview
Product Development
Manufacturing
LabPMM®
Global Regulatory Expertise
SCIENCE
Science Overview
Personalized Medicine
PUBLICATIONS
Featured Publication
Latest Publications
NEWSROOM
Latest News
Publications
Press Releases
Videos
Posters
Conferences
CAREERS & CULTURE
COMPANY
Support
Company
About Us
Our Mission, Vision & Values
Leadership Team
Board of Directors
Legal Notices
Newsroom
Global Distributors
Licensure and Certifications
Shop Corporate Gear
Invivoscribe Locations
Invivoscribe, Inc. (USA)
Invivoscribe, SARL (France)
Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
Clinical Lab Locations
LabPMM, LLC (USA)
LabPMM, GmbH (Germany)
LabPMM, GK (Japan)
Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
CONTACT
LATEST NEWS
Invivoscribe Announces Key Submission in the EU⟶
CONNECT